AlzChem Group AG (ALZCF) Q2 2026 Earnings Call July 30, 2026 4:00 AM EDT
Company Participants
Andreas Niedermaier – CEO & Chairman of Executive Board
Andreas Losle – CFO & Member of Management Board
Conference Call Participants
Christian Faitz – Kepler Cheuvreux, Research Division
Julia Winckelmann – BofA Securities, Research Division
Peter-Thilo Hasler – Sphene Capital GmbH
Patrick Speck – Montega AG
Manuela Stuerzer – Deutsche Bank AG, Research Division
Presentation
Operator
Good morning, and a warm welcome to the earnings call of the AlzChem Group AG. I would like to introduce the company’s CEO, Andreas Niedermaier; and CFO, Andreas Losler, who will guide us through the presentation in a moment, followed by a Q&A session via audio line and chat.
And with that, I hand over to you, Mr. Niedermaier.
Andreas Niedermaier
CEO & Chairman of Executive Board
Yes. Thank you for the warm welcome, and good morning to everyone. It’s great to have you with us today. Thank you for joining for the first and quarter 2 analyst call. We will take you through the key highlights of the quarters first and then, as always, be available for questions.
So let’s get straight to the business and turn to Slide 5 here. Yes. Here we go. So let me briefly summarize our performance in the first half of 2026. We have delivered a very successful first 6 months here with both revenue and earnings significantly exceeding the prior year level. Group revenue increased by 6% year-on-year to almost EUR 304 million. Growth was driven by both higher volumes and an improved pricing environment, reflecting the continued strength of our specialty portfolio. At the same time, profitability once again developed significantly better than revenue.
EBITDA increased by 14% overall to EUR 64.5 million, while our EBITDA margin expanded from 19.6% to 21.2% overall. So this strong earnings
You must be logged in to post a comment Login